PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis.
about
The Herbal Drug Melampyrum pratense L. (Koch): Isolation and Identification of Its Bioactive Compounds Targeting Mediators of InflammationLiver X receptors inhibit human monocyte-derived macrophage foam cell formation by inhibiting fluid-phase pinocytosis of LDL15(S)-Lipoxygenase-1 associates with neutral lipid droplets in macrophage foam cells: evidence of lipid droplet metabolismReversal of high dietary fructose-induced PPARalpha suppression by oral administration of lipoxygenase/cyclooxygenase inhibitorsLipidome in colorectal cancerIdentification and Mechanism of 10-Carbon Fatty Acid as Modulating Ligand of Peroxisome Proliferator-activated ReceptorsMacrophage reprogramming by mycolic acid promotes a tolerogenic response in experimental asthmaOSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophagesTranscriptional profiling of human liver identifies sex-biased genes associated with polygenic dyslipidemia and coronary artery diseasePPAR Alpha PathwayEffects of PPARalpha on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle?Nuclear receptors as drug targets for metabolic disease.Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice.Dynamic transcriptomic profiles of zebrafish gills in response to zinc supplementation.Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liverGender disparity of hepatic lipid homoeostasis regulated by the circadian clockErythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid systemHigh density lipoproteins-based therapies for cardiovascular disease.Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy.Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptorsConcurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice.Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infectionThe inhibitory effects of bioactive compounds of tomato juice binding to hepatic HMGCR: in vivo study and molecular modelling.From SNP co-association to RNA co-expression: novel insights into gene networks for intramuscular fatty acid composition in porcineMolecular regulation of HDL metabolism and function: implications for novel therapies.The human myeloperoxidase gene is regulated by LXR and PPARalpha ligands.Chronic caloric restriction attenuates a loss of sulfatide content in PGC-1α-/- mouse cortex: a potential lipidomic role of PGC-1α in neurodegeneration.De novo transcriptome assembly and identification of genes associated with feed conversion ratio and breast muscle yield in domestic ducks.Future therapeutic directions in reverse cholesterol transport.The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells.Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies.Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 MiceResearch resource: nuclear receptor atlas of human retinal pigment epithelial cells: potential relevance to age-related macular degenerationTranscriptome Analysis Reveals Regulation of Gene Expression for Lipid Catabolism in Young Broilers by Butyrate Glycerides.Adipose tissue signaling by nuclear receptors in metabolic complications of obesityPhosphatidic Acid (PA) can Displace PPARα/LXRα Binding to The EGFR Promoter Causing its Transrepression in Luminal Cancer CellsCurrent understanding of the role of high-density lipoproteins in atherosclerosis and senescence.Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targetsTranslational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS.Regulatory circuits controlling white versus brown adipocyte differentiation.
P2860
Q21285073-30255D8E-7AE7-4C25-9828-301577250A50Q24337296-CCD4C981-B2AF-48A7-A844-18E1C329B222Q24338520-EAC2B8A5-D32E-4961-9B37-516F9C6829CEQ24814568-06454C5A-4CA8-40A6-AA7C-78A9A22519C5Q26766296-B093D265-C4C1-463A-97A1-D17F11CED9F9Q27675297-7A36A353-15B9-4C71-AD57-89DFFB06368AQ28238435-AF902F0E-3CA3-4FE7-B4E2-468F0293C98CQ28256750-A92464D6-AD00-44B3-BE70-FD56B2DA50CDQ28476544-7E397031-189C-488D-992B-F619DC0DF9F7Q30151267-2825A999-04C4-474D-89CD-06B8DD736A50Q30353176-16772A17-D91D-49D8-9C37-118949469405Q30430126-A31533B9-D31A-4DAB-A608-692E88BD9EE4Q33236495-6A9EFEE4-D0EB-4920-831A-7253D25802D8Q33714968-5B6C2E85-1180-489D-8791-3E42521C2662Q33796272-14B534C5-34FF-4329-AFE7-58D1C96C5C7FQ34048254-A7EEAF38-1336-4B95-8604-656237FE41DBQ34100489-D8DADE60-FCC5-488F-A3E6-40B52ADF67BAQ34313937-41BABC10-7B44-4AC9-908B-0757DEEAA151Q34626341-01D243D4-71A1-45CF-868C-C160E4319E62Q34658555-BDE0ABBD-C823-42EB-8FFC-78FC469D8FA2Q34770055-438A685F-CBD7-4AC4-AA1B-7A70B69EC54FQ34981779-B84C0110-947E-44D3-8EAD-DFF63A104B1CQ35083289-854D65BF-5789-4143-9253-36E2442C8678Q35130723-70A65633-0FDF-4E51-BD28-9862BD1594E4Q35191066-58BA9B49-DA21-4644-9E0F-55D7621DF3A6Q35697554-549BCDDA-D96E-4889-B603-207E3F7949AEQ35715576-9CC6E19D-29BB-4DA3-9DC9-63180D4D559AQ35834739-B744505A-42C2-4BD9-8E27-7D23B607C1B8Q35860010-3C156CB0-2B3B-43F3-B3D7-2F216EB83744Q35865044-EC71CBA6-ADF9-4939-8801-92C82E586756Q36007212-2E82C073-7751-4070-BA33-3B40BCEE6CF1Q36065117-D08E6CF1-47D9-4356-B111-A4DD4A6DCCFFQ36067442-BC1F12A9-E1DE-4F1B-A9E3-792DF4E595DEQ36100254-2B26386E-3478-47E6-A61F-E3503B93CF0BQ36176430-26C52152-A63B-41D4-B1E8-CC32D13AC6ABQ36192286-5140D46F-E8ED-4E5D-AA9B-4E7B830E2A4BQ36314862-5C1BB884-9B96-42D9-95B5-39DEEF849937Q36383197-C67DCF4B-D85C-40F5-BE9B-F1CDF3A5E2B1Q36394283-8428D8B3-EBA0-415F-A8A5-ED5223F6D6E6Q36561080-DD914593-2C60-4767-9F28-96D2C4D7F94F
P2860
PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
PPAR- and LXR-dependent pathwa ...... evelopment of atherosclerosis.
@ast
PPAR- and LXR-dependent pathwa ...... evelopment of atherosclerosis.
@en
type
label
PPAR- and LXR-dependent pathwa ...... evelopment of atherosclerosis.
@ast
PPAR- and LXR-dependent pathwa ...... evelopment of atherosclerosis.
@en
prefLabel
PPAR- and LXR-dependent pathwa ...... evelopment of atherosclerosis.
@ast
PPAR- and LXR-dependent pathwa ...... evelopment of atherosclerosis.
@en
P1476
PPAR- and LXR-dependent pathwa ...... evelopment of atherosclerosis.
@en
P2093
Andrew C Li
Christopher K Glass
P304
P356
10.1194/JLR.R400010-JLR200
P577
2004-10-16T00:00:00Z